153 related articles for article (PubMed ID: 20681062)
21. Trial results finally show potential for microbicidal HIV gel.
Mohammadi D
Lancet Infect Dis; 2010 Sep; 10(9):587. PubMed ID: 20815108
[No Abstract] [Full Text] [Related]
22. A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection.
Gengiah TN; Baxter C; Mansoor LE; Kharsany AB; Abdool Karim SS
Expert Opin Investig Drugs; 2012 May; 21(5):695-715. PubMed ID: 22394224
[TBL] [Abstract][Full Text] [Related]
23. Adherence in the CAPRISA 004 tenofovir gel microbicide trial.
Mansoor LE; Abdool Karim Q; Yende-Zuma N; MacQueen KM; Baxter C; Madlala BT; Grobler A; Abdool Karim SS
AIDS Behav; 2014 May; 18(5):811-9. PubMed ID: 24643315
[TBL] [Abstract][Full Text] [Related]
24. Antiretroviral chemoprophylaxis: new successes and questions.
Mayer KH
Lancet; 2015 Jun; 385(9984):2236-7. PubMed ID: 25769358
[No Abstract] [Full Text] [Related]
25. Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.
Minnis AM; Gandham S; Richardson BA; Guddera V; Chen BA; Salata R; Nakabiito C; Hoesley C; Justman J; Soto-Torres L; Patterson K; Gomez K; Hendrix CW
AIDS Behav; 2013 Feb; 17(2):737-47. PubMed ID: 23065145
[TBL] [Abstract][Full Text] [Related]
26. AIDS: Drugs that prevent HIV infection.
Wainberg MA
Nature; 2011 Jan; 469(7330):306-7. PubMed ID: 21248832
[No Abstract] [Full Text] [Related]
27. Integrating HIV prevention into practice.
Mathers BM; Cooper DA
JAMA; 2014 Jul 23-30; 312(4):349-50. PubMed ID: 25038352
[No Abstract] [Full Text] [Related]
28. Tenofovir trials raise ethical issues.
Mills E
HIV AIDS Policy Law Rev; 2005 Aug; 10(2):31-2. PubMed ID: 16365973
[TBL] [Abstract][Full Text] [Related]
29. The introduction of new antiretroviral-based HIV prevention methods into health systems: an update.
Daly F
Reprod Health Matters; 2012 Jun; 20(39):215. PubMed ID: 22789099
[No Abstract] [Full Text] [Related]
30. Diverse approaches useful for microbicide trials.
Abdool Karim SS; Abdool Karim Q
Nature; 2007 Sep; 449(7158):24. PubMed ID: 17805274
[No Abstract] [Full Text] [Related]
31. Disinhibition and risk compensation: scope, definitions, and perspective.
Hogben M; Liddon N
Sex Transm Dis; 2008 Dec; 35(12):1009-10. PubMed ID: 18936724
[No Abstract] [Full Text] [Related]
32. Preexposure prophylaxis reduces HIV risk in injection-drug users.
Rosenberg K
Am J Nurs; 2013 Sep; 113(9):17. PubMed ID: 23985594
[No Abstract] [Full Text] [Related]
33. Preventing HIV in women--still trying to find their VOICE.
Saag MS
N Engl J Med; 2015 Feb; 372(6):564-6. PubMed ID: 25651251
[No Abstract] [Full Text] [Related]
34. Many in VOICE trial didn't use provided prevention products.
AIDS Policy Law; 2015 Mar; 30(4):3. PubMed ID: 26094276
[No Abstract] [Full Text] [Related]
35. Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies.
Karim QA; Baxter C; Karim SA
BJOG; 2014 Oct; 121 Suppl 5(0 5):53-61. PubMed ID: 25335841
[TBL] [Abstract][Full Text] [Related]
36. Vaginal deployment and tenofovir delivery by microbicide gels.
Gao Y; Yuan A; Chuchuen O; Ham A; Yang KH; Katz DF
Drug Deliv Transl Res; 2015 Jun; 5(3):279-94. PubMed ID: 25874971
[TBL] [Abstract][Full Text] [Related]
37. Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection.
Abdool Karim SS; Abdool Karim Q; Kharsany AB; Baxter C; Grobler AC; Werner L; Kashuba A; Mansoor LE; Samsunder N; Mindel A; Gengiah TN;
N Engl J Med; 2015 Aug; 373(6):530-9. PubMed ID: 26244306
[TBL] [Abstract][Full Text] [Related]
38. HIV basics.
Miller N
Midwifery Today Int Midwife; 2004; (72):30-3. PubMed ID: 15651449
[No Abstract] [Full Text] [Related]
39. Preservation HIV-1-specific IFNγ+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial.
Mureithi MW; Poole D; Naranbhai V; Reddy S; Mkhwanazi NP; Sibeko S; Werner L; Abdool Karim Q; Abdool Karim S; Ndung'u T; Altfeld M;
J Acquir Immune Defic Syndr; 2012 Jun; 60(2):124-7. PubMed ID: 22362152
[TBL] [Abstract][Full Text] [Related]
40. Early nonresponse for tenofovir regimen.
AIDS Patient Care STDS; 2003 Nov; 17(11):603. PubMed ID: 14748354
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
